The main metabolic pathway of oracin, a new potential cytostatic drug, in human liver microsomes and cytosol: Stereoselectivity of reoxidation of theprincipal metabolite 11-dihydrooracin to oracin
V. Wsol et al., The main metabolic pathway of oracin, a new potential cytostatic drug, in human liver microsomes and cytosol: Stereoselectivity of reoxidation of theprincipal metabolite 11-dihydrooracin to oracin, ENANTIOMER, 5(3-4), 2000, pp. 263-270
Chirality is a prominent feature of most biological processes. The intrinsi
c asymmetry of receptors, enzymes, and other endogenous macromolecules repr
esents the basis for biological discrimination between the stereoisomeric f
orms of all foreign compounds in organism. Stereoselectivity and stereospec
ificity, two principal chiral attributes of enzyme activity, play important
role in biotransformation process of drugs and other xenobiotics. The ster
eospecificity of enzymes leads to the preferential formation of certain ena
ntiomer, the stereoselectivity of enzymes, on the other hand, expresses the
preference of one stereoisomer form of substrate for subsequent biotransfo
rmation. An approach to the study of different conditions for the formation
of the two enantiomers of principal metabolite of potential cytostatic dru
g oracin in Man in vitro is described. The futile cycle, in which the princ
ipal metabolite is converted to the parent drug, is also discussed. The res
ults emphasise the fact that the stereospecificity of enzymes in Man is oft
en distinct from other laboratory species studied.